Novo Nordisk’s popular diabetes treatment Ozempic might undergo pricing talks with Medicare in 2025
The widely-used diabetes treatment, Ozempic, created by Novo Nordisk, could become the focus of pricing discussions between manufacturers and Medicare. This move is part of [more…]